Apoptosis by dietary agents for prevention and treatment of prostate cancer

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages

  Khan, Naghma ^a   Adhami, Vaqar Mustafa ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; EPIGALLOCATECHIN GALLATE; FISETIN; GENISTEIN; LUPEOL; LYCOPENE; POMEGRANATE EXTRACT; RESVERATROL; TUMOR MARKER;

ABSENCE OF SIDE EFFECTS; APOPTOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL; DIET THERAPY; DRUG BINDING; DRUG INHIBITION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IN VITRO STUDY; LATENT PERIOD; MITOCHONDRIAL MEMBRANE; NONHUMAN; POMEGRANATE; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TEA;

ADENOCARCINOMA; AGED; ANIMALS; APOPTOSIS; CAROTENOIDS; CATECHIN; CLINICAL TRIALS AS TOPIC; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; GENISTEIN; HUMANS; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC; MIDDLE AGED; NEOPLASM PROTEINS; PENTACYCLIC TRITERPENES; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; PUNICACEAE; STILBENES; TUMOR CELLS, CULTURED;

EID: 77449090086     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0262     Document Type: Review

References (82)

1. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M & Mukhtar H 2007 Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clinical Cancer Research 13 1611-1619.
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R & Mukhtar H 1997 Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Journal of the National Cancer Institute 89 1881-1886.
3. Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman I, Geldof AA & Campbell MJ 2004 Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 7 274-283.
4. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R & Kinae N 2000 Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. Journal of Nutrition 130 2243-2250.
5. Athar M, Back JH, Kopelovich L, Bickers DR & Kim AL 2009 Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Archives of Biochemistry and Biophysics 486 95-102.
6. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D & Fuhrman B 2000 Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. American Journal of Clinical Nutrition 71 1062-1076.
7. Aziz MH, Nihal M, Fu VX, Jarrard DF & Ahmad N 2006 Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Molecular Cancer Therapeutics 5 1335-1341.
8. Bemis DL, Capodice JL, Desai M, Buttyan R & Katz AE 2004 A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clinical Cancer Research 10 5282-5292.
9. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM & Castellon EA 2007 Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. Journal of Andrology 28 282-293.
10. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G & Corti A 2006 Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Research 66 1234-1240.
11. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G & Swinnen JV 2003 Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. International Journal of Cancer 106 856-862.
12. Caporali A, Davalli P, Astancolle S, D'Arca D, Brausi M, Bettuzzi S & Corti A 2004 The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25 2217-2224.
13. Chendil D, Ranga RS, Meigooni D, Sathishkumar S & Ahmed MM 2004 Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23 1599-1607.
14. Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L & Gallant V 2005 A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urologic Oncology 23 108-113.
15. Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY & Kwok TT 2001 Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sciences 68 1207-1214.
16. Deeb DD, Jiang H, Gao X, Divine G, Dulchavsky SA & Gautam SC 2005 Chemosensitization of hormonerefractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. Journal of Experimental Therapeutics and Oncology 5 81-91.
17. Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA & Gautam SC 2007 Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5- dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. Journal of Pharmacology and Experimental Therapeutics 321 616-625.
18. Dorai T, Cao YC, Dorai B, Buttyan R & Katz AE 2001 Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47 293-303.
19. Fadeel B & Orrenius S 2005 Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. Journal of Internal Medicine 258 479-517.
20. Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wahala K & Adlercreutz H 1998 Phytoestrogens and inhibition of angiogenesis. Bailliere's Clinical Endocrinology and Metabolism 12 649-666.
21. Fulda S & Debatin KM 2004 Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Research 64 337-346.
22. Geetha T & Varalakshmi P 2001 Anti-inflammatory activity of lupeol and lupeol linoleate in rats. Journal of Ethnopharmacology 76 77-80.
23. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM & Kader AA 2000 Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry 48 4581-4589.
24. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM & Watson RW 2007 Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67 1641-1653.
25. Gupta S, Ahmad N, Nieminen AL & Mukhtar H 2000 Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (K)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicology and Applied Pharmacology 164 82-90.
26. Gupta S, Hastak K, Ahmad N, Lewin JS & Mukhtar H 2001 Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. PNAS 98 10350-10355.
27. Hanneken A, Lin FF, Johnson J & Maher P 2006 Flavonoids protect human retinal pigmentepithelial cells from oxidative-stress-induced death. Investigative Ophthalmology & Visual Science 47 3164-3177.
28. Hantz HL, Young LF & Martin KR 2005 Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Experimental Biology and Medicine 230 171-179.
29. Harper CE, Patel BB, Wang J, Eltoum IA & Lamartiniere CA 2007 Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate 67 1576-1589.
30. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML & Mukhtar H 2003 Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22 4851-4859.
31. Hastak K, Agarwal MK, Mukhtar H & Agarwal ML 2005 Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB Journal 19 789-791.
32. Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, Kawase I & Tanaka T 2003 Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. Journal of Allergy and Clinical Immunology 111 1299-1306.
33. Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, Yudelev M, Joiner MC, Marples B, Forman JD & Sarkar FH 2004 Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Molecular Cancer Therapeutics 3 1271-1279.
34. Horvath Z, Marihart-Fazekas S, Saiko P, Grusch M, Ozsuy M, Harik M, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M et al. 2007 Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines. Anticancer Research 27 3459-3464.
35. Iannolo G, Conticello C, Memeo L & De Maria R 2008 Apoptosis in normal and cancer stem cells. Critical Review in Oncology and Hematology 66 42-51.
36. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES & Cox ME 2007 Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clinical Nutrition 26 252-263.
37. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG et al. 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218-220.
38. Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, Husband AJ, Pedersen JS, Frydenberg M & Risbridger GP 2002 Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiology, Biomarkers and Prevention 11 1689-1696.
39. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY et al. 2003 A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97 1442-1446.
40. Jemal A, Siegel R, Ward E, Hao Y, Xu J & Thun MJ 2009 Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 59 225-249.
41. Jian L, Xie LP, Lee AH & Binns CW 2004 Protective effect of green tea against prostate cancer: a case-control study in Southeast China. International Journal of Cancer 108 130-135.
42. Kazi A, Daniel KG, Smith DM, Kumar NB & Dou QP 2003 Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochemical Pharmacology 66 965-976.
43. Kerr JF, Wyllie AH & Currie AR 1972 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26 239-257.
44. Khan N, Afaq F & Mukhtar H 2007 Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis 28 233-239.
45. Khan N, Afaq F & Mukhtar H 2008a Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxidants & Redox Signaling 10 475-510.
46. Khan N, Afaq F, Syed DN & Mukhtar H 2008b Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 29 1049-1056.
47. Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X et al. 2006 Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Research 66 613-621.
48. Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R & Christov K 2003 Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutrition and Cancer 47 40-47.
49. Kim JH, Xu C, Keum YS, Reddy B, Conney A & Kong AN 2006 Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27 475-482.
50. Kumi-Diaka J, Saddler-Shawnette S, Aller A & Brown J 2004 Potential mechanism of phytochemical-induced apoptosis in human prostate adenocarcinoma cells: therapeutic synergy in genistein and beta-lapachone combination treatment. Cancer Cell International 4 5.
51. Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR, Abrams J, Cher ML & Sarkar FH 2004 Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia 6 354-363.
52. Li M, Zhang Z, Hill DL, Chen X, Wang H & Zhang R 2005 Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Research 65 8200-8208.
53. Maher P 2006 A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives. Free Radical Research 40 1105-1111.
54. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN & Mukhtar H 2005 Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. PNAS 102 14813-14818.
55. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M & Cardelli JA 2009 Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prevention Research 2 673-682.
56. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P & Aggarwal BB 2001 Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20 7597-7609.
57. Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T & Wakabayashi K 1998 Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Japanese Journal of Clinical Oncology 28 360-363.
58. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R et al. 2006 Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clinical Cancer Research 12 4018-4026.
59. Prasad S, Nigam N, Kalra N & Shukla Y 2008a Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells. Molecular Carcinogenesis 47 916-924.
60. Prasad S, Kalra N & Shukla Y 2008b Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells. Nutrition and Cancer 60 120-130.
61. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH & Hillman GG 2006 Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6 107.
62. Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM et al. 2008 Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaBdependent mechanism. Molecular Cancer Therapeutics 7 2662-2671.
63. Reynolds AR & Kyprianou N 2006 Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. British Journal of Pharmacology 147 (Suppl 2) S144-S152.
64. Saleem M, Kweon MH, Yun JM, Adhami VM, Khan N, Syed DN & Mukhtar H 2005 A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgensensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Research 65 11203-11213.
65. Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wei S & Djeu JY 2007 Clusterin mediates TRAIL resistance in prostate tumor cells. Molecular Cancer Therapeutics 6 2938-2947.
66. Savill J & Fadok V 2000 Corpse clearance defines the meaning of cell death. Nature 407 784-788.
67. Seeni A, Takahashi S, Takeshita K, Tang M, Sugiura S, Sato SY & Shirai T 2008 Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pacific Journal of Cancer Prevention 9 7-14.
68. Shankar S, Chen Q, Sarva K, Siddiqui I & Srivastava RK 2007a Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. Journal of Molecular Signaling 2 10.
69. Shankar S, Chen Q, Siddiqui I, Sarva K & Srivastava RK 2007b Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,4′,5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential. Journal of Molecular Signaling 2 7.
70. Shankar S, Ganapathy S, Chen Q & Srivastava RK 2008 Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Molecular Cancer 7 16.
71. Siddiqui IA, Zaman N, Aziz MH, Reagan-Shaw SR, Sarfaraz S, Adhami VM, Ahmad N, Raisuddin S & Mukhtar H 2006 Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis 27 833-839.
72. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S & Mukhtar H 2008a Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27 2055-2063.
73. Siddiqui IA, Shukla Y, Adhami VM, Sarfaraz S, Asim M, Hafeez BB & Mukhtar H 2008b Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharmaceutical Research 25 2135-2142.
74. Smith DM, Wang Z, Kazi A, Li LH, Chan TH & Dou QP 2002 Synthetic analogs of green tea polyphenols as proteasome inhibitors. Molecular Medicine 8 382-392.
75. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, Okugi H, Sekine Y, Oki K, Ito K et al. 2002 Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. International Journal of Cancer 99 846-852.
76. Syed DN, Khan N, Afaq F & Mukhtar H 2007 Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiology, Biomarkers and Prevention 16 2193-2203.
77. Tang L, Jin T, Zeng X & Wang JS 2005 Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. Journal of Nutrition 135 287-290.
78. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC & de Vere White RW 2007 GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Prostate 67 521-535.
79. Venkateswaran V, Klotz LH, Ramani M, Sugar LM, Jacob LE, Nam RK & Fleshner NE 2009 A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model. Cancer Prevention Research 2 473-483.
80. Wang S, DeGroff VL & Clinton SK 2003 Tomato and soy polyphenols reduce insulin-like growth factor-Istimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. Journal of Nutrition 133 2367-2376.
81. Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN et al. 2008 Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29 2001-2010.
82. Yuan-Jing F, Nan-Shan H & Lian X 2009 Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis. Cancer Letters 284 189-197.